Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.70%1.76B | 0.20%9.26B | 3.24%6.05B | 4.30%3.92B | -13.06%1.77B | -0.53%9.25B | -8.03%5.86B | -8.92%3.76B | 7.06%2.04B | -0.82%9.3B |
| Operating income | -0.70%1.76B | 0.20%9.26B | 3.24%6.05B | 4.30%3.92B | -13.06%1.77B | -0.53%9.25B | -8.03%5.86B | -8.92%3.76B | 7.06%2.04B | -0.82%9.3B |
| Operating expenses | 3.05%-1.07B | -2.10%-6.46B | -7.38%-3.84B | -6.68%-2.47B | 16.28%-1.1B | -6.30%-6.32B | 5.67%-3.57B | 6.65%-2.32B | -14.26%-1.31B | 6.36%-5.95B |
| Gross profit | 3.15%692.75M | -3.90%2.81B | -3.23%2.21B | 0.49%1.45B | -7.23%671.62M | -12.69%2.92B | -11.48%2.29B | -12.35%1.44B | -3.94%723.98M | 10.83%3.35B |
| Selling expenses | 74.30%-770.48K | 27.71%-9.18M | 23.34%-7.13M | 28.03%-4.82M | 23.11%-3M | 35.83%-12.7M | 36.21%-9.3M | 43.39%-6.69M | 45.94%-3.9M | 44.38%-19.79M |
| Administrative expenses | 3.78%-82.34M | 5.17%-436.3M | -8.22%-300.6M | 1.29%-168.51M | 3.95%-85.58M | 4.78%-460.06M | 3.18%-277.76M | 6.54%-170.72M | 5.46%-89.1M | -8.89%-483.18M |
| Research and development expenses | -57.36%-6.89M | -35.72%-44.7M | -12.81%-25.98M | -7.56%-14.84M | 29.75%-4.38M | 1.63%-32.93M | -16.29%-23.03M | 0.80%-13.8M | -2.54%-6.23M | 27.97%-33.48M |
| Profit from asset sales | ---3.51K | -65.64%3.03M | -91.91%40.74K | 42.26%-54.93K | ---- | -35.33%8.83M | -96.05%503.42K | -100.75%-95.13K | 316.77%26.96K | 87.11%13.65M |
| Revaluation surplus | -258.77%-18.67M | 3,458.79%94.02M | 141.68%91.82M | 360.45%76.42M | 118.66%11.76M | -98.28%2.64M | -76.61%37.99M | -119.79%-29.34M | -11,580.55%-63.01M | 61.39%153.61M |
| -Changes in the fair value of other assets | -258.77%-18.67M | 3,458.79%94.02M | 141.68%91.82M | 360.45%76.42M | 118.66%11.76M | -98.28%2.64M | -76.61%37.99M | -119.79%-29.34M | -11,580.55%-63.01M | 61.39%153.61M |
| Impairment and provision | 37.08%-3.76M | -27.66%-745.62M | 28.30%-96.86M | 30.77%-92.16M | -116.60%-5.98M | -151.27%-584.05M | -152.60%-135.09M | -134.40%-133.12M | -212.74%-2.76M | 6.03%-232.43M |
| -Other impairment is provision | 37.08%-3.76M | -27.66%-745.62M | 28.30%-96.86M | 30.77%-92.16M | -116.60%-5.98M | -151.27%-584.05M | -152.60%-135.09M | -134.40%-133.12M | -212.74%-2.76M | 6.03%-232.43M |
| Special items of operating profit | -5.56%241.06M | -21.70%821.07M | -15.31%684.36M | -27.70%424.29M | -31.28%255.26M | -32.38%1.05B | 20.80%808.07M | 55.51%586.84M | 73.33%371.46M | -0.97%1.55B |
| Operating profit | -1.81%807.77M | -14.32%2.43B | -4.87%2.52B | -0.69%1.64B | -10.53%822.64M | -33.39%2.83B | -12.36%2.65B | -12.89%1.65B | 7.89%919.47M | 9.81%4.25B |
| Financing income | -57.81%13.04M | -4.62%71.36M | -13.87%57.02M | -2.78%41.89M | 17.55%30.91M | 5.88%74.81M | -20.92%66.2M | 26.41%43.09M | 18.23%26.3M | -45.51%70.66M |
| Financing cost | 24.15%-181.83M | 18.91%-859.37M | 26.29%-641M | 22.82%-441.66M | 21.95%-239.72M | 13.78%-1.06B | 6.64%-869.68M | 2.75%-572.28M | -4.28%-307.12M | -3.76%-1.23B |
| Special items of earning before tax | -76.65%37.88K | -4.14%-38.21M | -370.64%-11.46M | -44.42%2.76M | -94.38%162.19K | 62.48%-36.69M | 105.25%4.23M | 115.10%4.97M | 291.74%2.89M | -3,726.65%-97.78M |
| Earning before tax | 8.30%672.86M | -6.34%1.65B | 2.26%1.94B | 14.15%1.26B | -2.58%621.28M | -39.69%1.76B | -4.54%1.9B | -8.44%1.1B | 7.94%637.7M | 17.35%2.92B |
| After-tax profit from continuing operations | 8.01%555.49M | -2.67%1.19B | 6.44%1.6B | 21.09%1.03B | 0.31%514.28M | -48.94%1.22B | -3.72%1.5B | -8.56%851.18M | 9.43%512.67M | 22.02%2.39B |
| Earning after tax | 8.01%555.49M | -2.67%1.19B | 6.44%1.6B | 21.09%1.03B | 0.31%514.28M | -48.94%1.22B | -3.72%1.5B | -8.56%851.18M | 9.43%512.67M | 22.02%2.39B |
| Minority profit | 27.37%46.2M | -50.39%36.29M | 0.25%126.94M | -8.48%70.77M | -13.03%36.27M | 24.78%73.16M | 543.38%126.63M | 4,893.93%77.32M | 60.71%41.71M | 195.66%58.63M |
| Profit attributable to shareholders | 6.54%509.29M | 0.38%1.15B | 7.01%1.47B | 24.04%959.89M | 1.50%478.01M | -50.80%1.15B | -10.71%1.37B | -16.72%773.86M | 6.42%470.96M | 15.41%2.33B |
| Basic earnings per share | -5.42%0.192 | -2.72%0.429 | 1.59%0.575 | 22.44%0.382 | 4.10%0.203 | -55.09%0.441 | -11.84%0.566 | -18.75%0.312 | 7.14%0.195 | 17.04%0.982 |
| Diluted earnings per share | -5.42%0.192 | -2.72%0.429 | 1.59%0.575 | 22.44%0.382 | 4.10%0.203 | -55.09%0.441 | -11.84%0.566 | -18.75%0.312 | 7.14%0.195 | 17.04%0.982 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.